Pre- and post-EndoPredict endocrine therapy regimens.
收藏数据链接：
官方服务：
资源简介：
Pre- and post-EndoPredict endocrine therapy regimens.
应用场景：
创建时间：
2020-03-11
相关数据集
Supplementary Material for: The risk of cardiovascular disease following aromatase inhibitor therapy for breast cancer in postmenopausal women: a systematic review and meta-analysis
Background More women are recovering and living longer lives due to advancement in breast cancer therapies. Aromatase inhibitors (AI) are one form of endocrine therapy for breast cancer that may have
DataCite Commons2025-06-12 更新30
PRO-seq analysis of estradiol, OP-1250, fulvestrant and 4OH-tamoxifen treatments at multiple timepoints in breast cancer cells. PRO-seq analysis of estradiol, OP-1250, fulvestrant and 4OH-tamoxifen treatments at multiple timepoints in breast cancer cells
The estrogen receptor (ER) is a well-established target for the treatment of breast cancer, with the majority of patients presenting as ER-positive (ER+). Endocrine therapy is a mainstay of breast can
NIAID Data Ecosystem10
Cell-specific and spatio-temporal controls of the estrogen-responsive trefoil factor (TFF) locus activity.II.. Homo sapiens
Cell-specific transcriptional regulations exerted by the estrogen (E2) receptor alpha (ER) heavily rely upon timely and spatially coordinated processes. We engaged a comparative analysis of such dynam
NIAID Data Ecosystem10
Anti-prolif. effect of E2 in breast cancer cells that re-exp. ERalpha is mediated by aberr. regulat. of cell cycle genes
Gene expression changes caused by estrogen treatment of breast cancer cells that re-express ERalpha was investigated by infecting ER-negative MDA-MB-231 breast cancer cells for 24 h with recombinant a
NIAID Data Ecosystem20
